baber/WOPTO huggingface dataset:
Patent NZ-576897-A (NZ)
Title: Geothermal turbine
Inventor: SUZUKI ATSUHIDE
IPC: C22C38/00
Filed: 2003-01-28
Abstract: A geothermal turbine is disclosed. In one embodiment of the invention the geothermal turbine comprises a turbine casing, a rotor shaft, a plurality of nozzle diaphragm outer rings fixed to the turbine casing, a plurality of nozzle diaphragm inner rings located radially inside the nozzle diaphragm outer rings, a plurality of nozzles placed between the nozzle diaphragm outer rings and the nozzle diaphragm inner rings, which form a steam passage, and a plurality of rotor blades mounted on the turbine rotor shaft, which face the nozzles and form a blade cascade in a circumferential direction. Each rotor blade includes a plurality of cover pieces connecting tip portions of adjacent blades, where each cover piece includes a first tenon protruding from one side of the cover piece and a first tenon hole on an opposite side of the cover piece. The first tenon is inserted into a second tenon hole, which is located on a tip portion of a first blade. A second tenon protrudes from a second blade next to the first blade, and is inserted into the first tenon hole. The blade is continuously coupled 360 degrees around a wheel. (62) Divided Out of 554814
Patent NZ-579550-A (NZ)
Title: Co-production of power and hydrocarbons
Inventor: BOSHOFF JAN HENDRIK DUVENHAGE
IPC: C10G2/00
Filed: 2008-02-08
Abstract: Disclosed is a process for co-producing power and hydrocarbons, the process including; in a wet gasification stage, gasifying coal to produce a combustion gas at elevated pressure comprising at least H2 and CO; enriching a first portion of the combustion gas with H2 to produce an H2-enriched gas; generating power from a second portion of the combustion gas; in a dry gasification stage, gasifying coal to produce a synthesis gas precursor at elevated pressure comprising at least H2 and CO; mixing at least a portion of the H2-enriched gas with the synthesis gas precursor to provide a synthesis gas for hydrocarbon synthesis; and synthesising hydrocarbons from the synthesis gas.
Patent NZ-584178-A (NZ)
Title: Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides
Inventor: ZAMBACH WERNER
IPC: A01N43/90
Filed: 2008-10-13
Abstract: A compound of the formula I e.g. Carbonic acid 3-(5-bromo-3-fluoro-2-methyl-phenyl)-8-methoxy-2-oxo-1 ,8-diaza-spiro[4.5]dec-3-en-4-yl ester ethyl ester, wherein the substituents are defined on the specification or an agrochemically acceptable salt or an N-oxide thereof.
Patent NZ-586512-A (NZ)
Title: Toilet bowl connection to a cistern using two straight pipes entering from the rear of the bowl
Inventor: KRAMER JORG
IPC: E03D11/17
Filed: 2008-11-26
Abstract: A flush water unit for a toilet bowl is disclosed. The water unit has a plurality of outlet openings ending in the bowl interior (1) of a bowl body (2), through which flush water enters into the flusher bowl (1) from the rear of the bowl body (2) below the upper bowl edge (4). The outlet openings are configured on the respective front ends of separate, preferably substantially straight, feed pipes (6, 6'), that project from the outside into the interior of the bowl (1) and are insertable through at least one installation recess (7, 7') in the rear wall (8) of the bowl body.
Patent NZ-587077-A (NZ)
Title: A hydroelectric turbine with floating rotor where the rotors moves hypocycloidally relative to the stator
Inventor: IVES JAMES
IPC: F03B13/08
Filed: 2009-02-05
Abstract: A hydroelectric turbine 10 comprises a stator 12 and a shaftless rotor 14. The stator 12 defines an opening in which the rotor 14 is housed for rotation. The opening is shaped and dimensioned to permit the rotor 14 to undergo rotation about a central axis of the rotor 14, and displacement along the circumference of the opening in a direction opposite to that in which the rotor 14 is rotating.
Patent NZ-589645-A (NZ)
Title: Managing a handover operation wherein a trigger event with located status information is detected which includes a handover complete message
Inventor: MAHESHWARI SHAILESH
IPC: H04L1/00
Filed: 2009-06-19
Abstract: 589645 Disclosed is a method of managing a handover operation in a wireless communication system. Data to be transmitted over one or more communication channels is identified. Status information associated with respective communication channels is located among the identified data. A triggering event, which includes a transmission of a handover complete message, is detected on which the located status information is to be transmitted. The located status information is transmitted in a first transmission after detecting the triggering event. The first transmission occurs prior to transmission of at least a portion of remaining identified data.
Patent NZ-592516-A (NZ)
Title: Antibodies to il-6 and use thereof
Inventor: GARCIA-MARTINEZ LEON
IPC: A61K39/00
Filed: 2009-11-24
Abstract: Disclosed are therapeutic methods using IL-6 antagonists such as an Ab 1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof Patients will preferably comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others.
Patent NZ-592760-A (NZ)
Title: Tanning process and tanning composition
Inventor: TRIMARCO LICIA
IPC: C07D251/44
Filed: 2010-03-04
Abstract: Disclosed are a process for the production of tanned leather, skins or pelts by non-metal tanning, comprising the step of tanning a bated hide, skin or pelt with a tanning agent (A), the tanning agent (A) being at least one compound of formula (I) such as sodium 4-(4,6-dichloro-1,3,5-triazin-2-yl)benzene sulphonate, the aqueous solution comprising agent (A) of formula (I), the use of the tanned leather, skins or pelts produced by the said process and the tanned leather, skins or pelts obtained by the said process.
Patent NZ-593738-A (NZ)
Title: A barrier comprising a kickboard with rigid elongate base and a resilient member
Inventor: PANDAZOPOULOS ANDREW
IPC: E04G1/00
Filed: 2007-12-11
Abstract: A barrier assembly employed on construction sites that can be used as temporary fencing and rail systems for floor slab edge installation during the construction of multi storey buildings is disclosed. The barrier assembly (10) has an upright frame (15) that supports a barrier (20) consisting of a pair of barrier members (22, 23) that slide relative to each other so that they are adjustable in length. These barrier members are supported by a stirrup (19) as well as the frame (15).
Patent NZ-597094-A (NZ)
Title: Integrated building based air handler for server farm cooling system with exhaust air captured in plenum ducts encasing rear of server racks
Inventor: NOTEBOOM SCOTT
IPC: G06F1/20
Filed: 2010-07-09
Abstract: 597094 Disclosed is a server cooling system for a computer server farm. The system comprises a first space defined by a floor, one or more lateral walls, and a roof. One or more openings are located on the roof or at least one of the one or more lateral walls and an enclosure is installed within the first space and defining a second space. A rack is installed in the first space and engaging the enclosure in a substantially sealed manner. One or more rack-mounted units can be installed in the rack such that front faces of the rack-mounted units interface with the first space, and that back faces of the rack-mounted units interface with the second space. One or more cooling fans in the rack are operable to draw air from the first space through the front faces of the one or more rack-mounted units and expel heated air through the back faces of the one or more rack-mounted units to the second space. At least part of the heated air in the second space defined by the enclosure exits the server cooling system through at least one of the one or more openings. A control system is operably connected to the one or more openings to selectively activate the one or more openings based on temperatures observed within and outside the first space. The first space can be defined by a ceiling which creates a third space between the ceiling and roof, where ceiling openings allow air to move from the third space to the first space.
Patent NZ-597494-A (NZ)
Title: Method for interactive digital cinema system
Inventor: VANDENBULCKE NICK
IPC: H04N21/422
Filed: 2010-06-15
Abstract: 597494 Disclosed is a data management system, when used in a theatre, for an interactive digital cinema. The system includes input means (11) for collecting digital data from members of an audience (10), and processing means (16) for processing the data. The data management system further includes a digital content interface (15) for interfacing the processed data with a digital content server (17) providing interactive content to the audience (10).
Patent NZ-599592-A (NZ)
Title: Organ cold storage composition and methods of use
Inventor: MACMILLAN-CROW LEE ANN
IPC: A01N1/02
Filed: 2010-11-18
Abstract: 599592 Disclosed is a method of reducing oxidative damage to an organ that occurs during cold storage, the method comprising (i) first contacting the organ with a composition during cold storage of the organ, the composition comprising a mitochondrial-specific antioxidant and an organ preservation solution, and (ii) cold storing the organ in the composition, such that the composition reduces oxidative damage to an organ that occurs during cold storage.
Patent NZ-603623-A (NZ)
Title: Tcr complex immunotherapeutics
Inventor: ODEGARD VALERIE
IPC: C07K16/28
Filed: 2009-10-09
Abstract: Disclosed is a recombinant binding protein comprising a binding domain that specifically binds to a TCR complex, wherein the binding domain comprises the amino acid sequence as set forth in SEQ ID NO: 245 and the amino acid sequence as set forth in SEQ ID NOS:241, wherein the sequences are as disclosed in the complete specification. Also disclosed is the use of said recombinant binding protein in the manufacture of a medicament for treating an autoimmune disease selected from the group consisting of Crohn’s disease, ulcerative colitis, diabetes mellitus, asthma, and arthritis.
Patent NZ-603801-A (NZ)
Title: Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
Inventor: WALIGORA FRANK WALTER
IPC: A61K31/66
Filed: 2009-07-30
Abstract: Disclosed is a method for the preparation of a salt of isophosphoramide (or analog) of formula (E) comprising treating the neutral isophosphoramide (or analog) with a base under salt-forming conditions, wherein the salt-forming conditions comprise combining approximately equimolar amounts of tris(hydroxymethyl)aminomethane (also known as tris(hydroxymethyl)methylamine, Tris) and the neutral isophosphoramide (or analog).
Patent NZ-617700-A (NZ)
Title: Solids-handling equipment
Inventor: BAUMANN PAUL SMIT
IPC: F16K25/00
Filed: 2012-05-07
Abstract: Disclosed is a closure component (10) for solids-handling equipment. The closure component includes a closure body (12) configured to close a solids flow path by displacement of the closure body along a stroke axis (20), a removable tungsten carbide sealing element (14) attached to the closure body and is configured to sealingly engage an endless metallic seat spaced radially outwardly from the stroke axis when the closure body closes said solids flow path. The tungsten carbide sealing element is subject to brittle fracture and expands at a lesser rate than the closure body during heat expansion. The closure body includes at least one locating formation (see 36, figure 2) to engage and locate the metallic sealing element. The at least one locating formation is positioned radially outwardly from the stroke axis and more radially outwardly from the stroke axis than at least a portion of the metallic sealing element so that at least a portion of the metallic sealing element is positioned between the locating formation and the stroke axis. There is no locating formation radially inwardly of the tungsten carbide sealing element such that radially outward displacement of said radially inwardly locating formation as a result of heat expansion of the closure body is inhibited by the presence of the tungsten carbide sealing element. This formation advantageously prevents the fracture of the brittle tungsten carbide sealing element and the formation of gaps between the closure body and the seat due to deformation caused by differential thermal expansion of the closure body and the tungsten carbide sealing element.
Patent NZ-617790-A (NZ)
Title: Hydrophobic acrylic intraocular lens materials
Inventor: LAREDO WALTER R
IPC: A61L27/16
Filed: 2012-05-31
Abstract: Disclosed are low-tack, hydrophobic, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain 30-60% (w/w) of one or more aryl acrylic hydrophobic monomers of a compound of formula (I) as principal device-forming monomers, 0.1-3.9% (w/w) of a tack-reducing macromer additive of a dimethylacryloxypropyl-terminated polydimethylsiloxane (PDMS) compound of formula (II), 10-40% (w/w) of 2-ethylhexyl arcrylate or n-octyl acrylate, 5-30% (w/w) of a hydrophobic additive to reduce glistening, a cross linking component, and a reactive UV and/or blue-light absorber. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other implantable ophthalmic devices. Examples of a compound of formula (I) are: Benzyl acrylate, 2-phenylethyl acrylate, 2-phenoxyethyl acrylate, 4-phenylbutyl acrylate; 5-phenylpentyl acrylate, 2-benzyloxyethyl acrylate, 3-benzyloxypropyl acrylate; 3-phenylpropyl acrylate, 3-phenoxypropyl acrylate; 2-(phenylthio)propyl acrylate, and 2-(phenylthio)ethyl acrylate. Examples of a hydrophobic glistening-reducing additive are: Hydroxy(C2-C4 alkyl)methacrylates, glycerol methacrylate, and N-vinyl pyrrolidone (NVP). Examples of a suitable cross linking reagent are: Ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, allyl methacrylate, 1,3-propanediol dimethacrylate, 2,3-propanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1,4-butanediol dimethacrylate, and triethylene glycol dimethacrylate (TEGDMA). Examples of a reactive UV and/or blue-light absorber are: 2-(2’-hydroxy-3’-methallyl-5’-methylphenyl)benzotriazole, 3-(2H-benzo[d][1,2,3]triazol-2-yl)-4-hydroxyphenylethyl methacrylate, N-2-[3-(2’-methylphenylazo)-4-hydroxyphenyl]ethyl methacrylamide.
Patent NZ-622480-A (NZ)
Title: Meta-substituted biphenyl peripherally restricted faah inhibitors
Inventor: PIOMELLI DANIELE
IPC: C07D309/14
Filed: 2012-08-17
Abstract: The present disclosure provides methods of making and using peripherally restricted inhibitors of fatty acid amide hydrolase (FAAH). The present disclosure provides compounds of formula I and compositions that suppress FAAH activity and increases anandamide levels outside the central nervous system (CNS). The present disclosure also sets forth methods for inhibiting FAAH as well as methods for treating conditions such as, but not limited to, pain, inflammation, immune disorders, dermatitis, mucositis, the over reactivity of peripheral sensory neurons, neurodermatitis, and an overactive bladder. Accordingly, the disclosure also provides compounds, methods, and pharmaceutical compositions for treating conditions in which the selective inhibition of peripheral FAAH (as opposed to CNS FAAH) would be of benefit. In one embodiment the compound is [3-(3-carbamoylphenyl} -5 –hydroxy-phenyl] N- cyclohexylcarbamate.
Patent NZ-625984-A (NZ)
Title: Electric power switch
Inventor: ZHU XIN G
IPC: H01H31/28
Filed: 2011-04-18
Abstract: An electric power switch is disclosed including a shunt interrupter (20) operated by a shunt operating arm (70). The switch includes a cam (72) secured to a blade (30). The cam (72) is formed with a closing feature (76) to engage the shunt operating arm (70) to move it to a fully closed and latched position (as shown) upon closing of the switch. The switch provides circuit interruption for overhead distribution feeders.
Patent NZ-629578-A (NZ)
Title: Control of sexual maturation in animals
Inventor: CARLSON DANIEL F
IPC: C12N5/10
Filed: 2013-10-30
Abstract: A genetically modified livestock animal comprising a genome that comprises inactivation of a neuroendocrine gene selective for sexual maturation, with the inactivation of the gene preventing the animal from becoming sexually mature. The neuroendocrine gene may be selected from the group consisting of Gpr54, Kiss-1 or GnRH1. Inactivation may occur via nuclease inactivation or knockout of the gene. Methods of using, and processes of making, the animals are taught. Conventional livestock raising practices focus on the role of sexual maturity in livestock in terms of optimizing breeding and parturition.
Patent NZ-720748-A (NZ)
Title: Ezrin-derived peptides and pharmaceutical compositions thereof
Inventor: Rupert HOLMS
IPC: A61K38/17
Filed: 2016-06-01
Abstract: The present invention concerns ezrin-derived peptides, in particular, a peptide comprising an amino acid sequence of general formula (I) X1 EKKRRETVERE X2X3 (SEQ ID. No:5), wherein each X represents a non-polar amino acid residue and wherein the amino acid sequence is 14 to 25 residues in length. The invention further includes the use of these ezrin-derived peptides as immunostimulatory agents, and more specifically, for use in treating and preventing antiviral and treatment of diseases of the GI tract, in particular ulcerative disorders of the GI tract. The present invention also relates to pharmaceutical compositions comprising the peptides. Further, the invention relates to methods of treatment of infection and ulcerative diseases of the GI tract comprising administering the peptides to patients in need thereof.
Patent NZ-726636-A (NZ)
Title: Novel compounds and compositions for targeting cancer stem cells
Inventor: LI CHIANG JIA
IPC: C07D307/92
Filed: 2011-03-21
Abstract: Disclosed is the use of 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione (napabucasin) for treatment of cancer in a subject in need thereof, wherein the medicament is formulated for administration to the subject at a total daily dose in a range of from about 20 mg to about 2000 mg. Also disclosed is treatment where napabucasin is administered at a dose sufficient to achieve a blood concentration of the compound in the subject of at least 1.0 μΜ or above for at least two hours, wherein the blood concentration of the compound in the subject is substantially cleared within at most 24 hours.
Patent NZ-727329-A (NZ)
Title: Modular gantry structure
Inventor: DANNY DA SILVA
IPC: E04G5/12
Filed: 2016-12-08
Abstract: Sheltered walkways or gantries are sometimes constructed for pedestrians at or near construction sites. Known gantries are constructed from individual components such as timber, steel or concrete beams, walls and panels and often include bracing along one or more sides, and sometimes also a floor structure, to provide strength to the structure. In some situations, however, it may be desirable to leave the ground uncovered or to leave the walls of the structure open for access or aesthetic reasons. The present invention provides a structure for extending over a walkway or footpath. The structure includes a roof section, a plurality of legs extending substantially away from the roof section and a bracing structure connected between the roof section and a part of one or more of the legs proximal to the roof section. The bracing structure strengthens the structure so that a floor or other brace is not required between parts of the legs distal from the roof section. The roof section provides a continuous cover over the walkway or footpath and includes a substantially flat upper surface. In one form, the roof section can include a counterweight and may also include a plurality of corner castings and/or twist lock fittings positioned to conform to one or more standards for intermodal freight containers.
Patent NZ-741936-A (NZ)
Title: Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
Inventor: KAWABE TAKUMI
IPC: C07K7/06
Filed: 2016-10-24
Abstract: This invention provides compounds including peptides and peptidomimetics that can be used to treat cell proliferative disorders, such as those associated with benign and malignant tumor cells, and combinations of cisplatin or carboplatin, and immune checkpoint inhibitors. The invention compounds and combinations can be used to inhibit cell growth, such as treat a tumor or cancer.
Patent NZ-743526-A (NZ)
Title: Panel equipped with a photovoltaic device
Inventor: VIGNAL RENAUD
IPC: H02S40/34
Filed: 2015-07-01
Abstract: The invention relates to a panel equipped with a photovoltaic device constituted by an even number of columns of photovoltaic modules, the columns being aligned essentially parallel to a longitudinal edge of the panel, each column comprising an electrical pole on each of its extremities, the polarity of an electrical pole of one extremity being the inverse of that of the electrical pole of the other extremity, the poles of two adjacent columns being of inverse polarity, the electrical pole being in the form of a male connector when it is of one polarity and in the form of a female connector when it is of the inverse polarity and the male connectors and female connectors being arranged so that they interlock with one another when the lower transverse edge of an upper panel overlaps the upper transverse edge of a lower panel. The invention further relates to an assembly of panels according to the invention, to an electrical device capable of being connected to a converter comprising an assembly according to the invention and to a method for the electrical connection to a converter of the constituent panels of an assembly according to the invention. The purpose of the present invention is to remedy the following problems of the prior art: the connection of two successive modules is on the rear side, which may necessitate access to the roof boarding, if an uneven number of rows of modules is to be installed as a roof, the wiring becomes more complicated and requires a great deal of cable, the cables exit on the side of the roof, which also necessitates access to the roof boarding to connect the cables to the electrical grid.
Patent NZ-750812-A (NZ)
Title: Dispenser and dispenser monitoring systems and methods
Inventor: ELFSTRÖM BORIS ALLAN
IPC: A47K5/12
Filed: 2016-09-19
Abstract: An electromechanical switch is configured to operate when a hygiene product is dispensed, wherein upon pressing the switch, two separate signals are generated. The action of dispensing the hygiene product causes the electromechanical switch to convert the mechanical energy associated with the dispensing action into electrical energy. The dispenser is configured to use the electrical energy to emit a signal such that the dispenser emits a signal each time a hygiene product is dispensed. A system for monitoring the consumption of hygiene products in a dispenser includes a dispenser as described above and also a receiver for wirelessly receiving the emitted signal, the receiver being positioned remotely from the dispenser, and a central computer or server for receiving data from the receiver. A method of monitoring a dispenser for hygiene products is also provided.
Patent NZ-752572-A (NZ)
Title: Antisense oligonucleotides for the treatment of eye disease
Inventor: TURUNEN JANNE JUHA
IPC: C12N15/113
Filed: 2017-09-22
Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides (AONs) for skipping of exon 13 of human USH2A pre-mRNA that may be used in the treatment, prevention and/or delay of Usher syndrome type II and/or USH2A-associated non syndromic retina degeneration.